ID

28716

Beschreibung

Effects of Almonds On Endothelial Function In Patients With Coronary Artery Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01038362

Link

https://clinicaltrials.gov/show/NCT01038362

Stichworte

Versionen (1)
  1. 27.01.18 27.01.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

27. Januar 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Coronary Artery Disease NCT01038362

Englisch

Eligibility Coronary Artery Disease NCT01038362

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. male and female subjects.
Beschreibung

Gender

Datentyp

boolean

Alias
UMLS CUI [1]
C0079399
2. age range: 21-80 years old.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
3. weight less than 115 kg.
Beschreibung

Body Weight

Datentyp

boolean

Alias
UMLS CUI [1]
C0005910
4. clinically defined coronary artery disease that is clinical stable and compensated with appropriate treatment. coronary disease (cvd) is defined by the presence of lesions on coronary angiography, history of myocardial infarction, or positive stress test.
Beschreibung

Therapeutic procedure Coronary Artery Disease Stable | CVD | Lesion Coronary angiography | Myocardial Infarction | Stress Test Positive

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C1956346
UMLS CUI [1,3]
C0205360
UMLS CUI [2]
C0007222
UMLS CUI [3,1]
C0221198
UMLS CUI [3,2]
C0085532
UMLS CUI [4]
C0027051
UMLS CUI [5,1]
C3494508
UMLS CUI [5,2]
C1514241
5. willingness to give written informed consent and willingness and ability to understand, to participate to and to comply with the study requirements.
Beschreibung

Informed Consent | Protocol Compliance

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
UMLS CUI [2]
C0525058
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. history of nut allergy.
Beschreibung

Nut Hypersensitivity

Datentyp

boolean

Alias
UMLS CUI [1]
C0577620
2. pregnant or lactating women. pregnancy will be excluded by urine pregnancy test.
Beschreibung

Pregnancy | Breast Feeding | Urine pregnancy test

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0430056
3. clinical history of other major illness including end-stage cancer, renal failure, hepatic failure, gastrointestinal disorders that may impair absorption, or other conditions that in the opinion of the principal investigator make a clinical study inappropriate.
Beschreibung

Illness Major | End stage cancer | Kidney Failure | Liver Failure | Gastrointestinal Diseases Impairing Intestinal Absorption | Condition Study Subject Participation Status Inappropriate

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205164
UMLS CUI [2]
C0741884
UMLS CUI [3]
C0035078
UMLS CUI [4]
C0085605
UMLS CUI [5,1]
C0017178
UMLS CUI [5,2]
C0221099
UMLS CUI [5,3]
C0021826
UMLS CUI [6,1]
C0348080
UMLS CUI [6,2]
C2348568
UMLS CUI [6,3]
C1548788
4. treatment with an investigational new drug within the last 30 days.
Beschreibung

Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0013230
5. history of a psychological illness or condition such as to interfere with the subject's ability to understand the requirements of the study.
Beschreibung

Mental disorder Interferes with Comprehension Study Protocol | Condition Interferes with Comprehension Study Protocol

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C0162340
UMLS CUI [1,4]
C2348563
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C0162340
UMLS CUI [2,4]
C2348563
6. unwillingness to comply with the requirements of study including refraining from consumption of nuts and refraining from use of vitamin e, vitamin c, and beta carotene, lipoic acid, and/or other dietary or herbal supplements during the study.
Beschreibung

Protocol Compliance Unwilling | Avoidance Nuts | Avoidance Vitamin E | Avoidance Vitamin C | Avoidance Beta Carotene | Avoidance Lipoic Acid | Avoidance Dietary Supplements | Avoidance Herbal supplement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C0558080
UMLS CUI [2,1]
C0870186
UMLS CUI [2,2]
C0028723
UMLS CUI [3,1]
C0870186
UMLS CUI [3,2]
C0042874
UMLS CUI [4,1]
C0870186
UMLS CUI [4,2]
C0003968
UMLS CUI [5,1]
C0870186
UMLS CUI [5,2]
C0053396
UMLS CUI [6,1]
C0870186
UMLS CUI [6,2]
C0023791
UMLS CUI [7,1]
C0870186
UMLS CUI [7,2]
C0242295
UMLS CUI [8,1]
C0870186
UMLS CUI [8,2]
C1504473
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Coronary Artery Disease NCT01038362

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender
Item
1. male and female subjects.
boolean
C0079399 (UMLS CUI [1])
Age
Item
2. age range: 21-80 years old.
boolean
C0001779 (UMLS CUI [1])
Body Weight
Item
3. weight less than 115 kg.
boolean
C0005910 (UMLS CUI [1])
Therapeutic procedure Coronary Artery Disease Stable | CVD | Lesion Coronary angiography | Myocardial Infarction | Stress Test Positive
Item
4. clinically defined coronary artery disease that is clinical stable and compensated with appropriate treatment. coronary disease (cvd) is defined by the presence of lesions on coronary angiography, history of myocardial infarction, or positive stress test.
boolean
C0087111 (UMLS CUI [1,1])
C1956346 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0007222 (UMLS CUI [2])
C0221198 (UMLS CUI [3,1])
C0085532 (UMLS CUI [3,2])
C0027051 (UMLS CUI [4])
C3494508 (UMLS CUI [5,1])
C1514241 (UMLS CUI [5,2])
Informed Consent | Protocol Compliance
Item
5. willingness to give written informed consent and willingness and ability to understand, to participate to and to comply with the study requirements.
boolean
C0021430 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Nut Hypersensitivity
Item
1. history of nut allergy.
boolean
C0577620 (UMLS CUI [1])
Pregnancy | Breast Feeding | Urine pregnancy test
Item
2. pregnant or lactating women. pregnancy will be excluded by urine pregnancy test.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0430056 (UMLS CUI [3])
Illness Major | End stage cancer | Kidney Failure | Liver Failure | Gastrointestinal Diseases Impairing Intestinal Absorption | Condition Study Subject Participation Status Inappropriate
Item
3. clinical history of other major illness including end-stage cancer, renal failure, hepatic failure, gastrointestinal disorders that may impair absorption, or other conditions that in the opinion of the principal investigator make a clinical study inappropriate.
boolean
C0221423 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0741884 (UMLS CUI [2])
C0035078 (UMLS CUI [3])
C0085605 (UMLS CUI [4])
C0017178 (UMLS CUI [5,1])
C0221099 (UMLS CUI [5,2])
C0021826 (UMLS CUI [5,3])
C0348080 (UMLS CUI [6,1])
C2348568 (UMLS CUI [6,2])
C1548788 (UMLS CUI [6,3])
Investigational New Drugs
Item
4. treatment with an investigational new drug within the last 30 days.
boolean
C0013230 (UMLS CUI [1])
Mental disorder Interferes with Comprehension Study Protocol | Condition Interferes with Comprehension Study Protocol
Item
5. history of a psychological illness or condition such as to interfere with the subject's ability to understand the requirements of the study.
boolean
C0004936 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0162340 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0162340 (UMLS CUI [2,3])
C2348563 (UMLS CUI [2,4])
Protocol Compliance Unwilling | Avoidance Nuts | Avoidance Vitamin E | Avoidance Vitamin C | Avoidance Beta Carotene | Avoidance Lipoic Acid | Avoidance Dietary Supplements | Avoidance Herbal supplement
Item
6. unwillingness to comply with the requirements of study including refraining from consumption of nuts and refraining from use of vitamin e, vitamin c, and beta carotene, lipoic acid, and/or other dietary or herbal supplements during the study.
boolean
C0525058 (UMLS CUI [1,1])
C0558080 (UMLS CUI [1,2])
C0870186 (UMLS CUI [2,1])
C0028723 (UMLS CUI [2,2])
C0870186 (UMLS CUI [3,1])
C0042874 (UMLS CUI [3,2])
C0870186 (UMLS CUI [4,1])
C0003968 (UMLS CUI [4,2])
C0870186 (UMLS CUI [5,1])
C0053396 (UMLS CUI [5,2])
C0870186 (UMLS CUI [6,1])
C0023791 (UMLS CUI [6,2])
C0870186 (UMLS CUI [7,1])
C0242295 (UMLS CUI [7,2])
C0870186 (UMLS CUI [8,1])
C1504473 (UMLS CUI [8,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video